These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
189 related articles for article (PubMed ID: 35414540)
21. Progress in the care of familial hypercholesterolaemia: 2016. Bell DA; Watts GF Med J Aust; 2016 Sep; 205(5):232-6. PubMed ID: 27581271 [TBL] [Abstract][Full Text] [Related]
22. Heterozygous familial hypercholesterolaemia in a pair of identical twins: a case report and updated review. Mohd Nor NS; Al-Khateeb AM; Chua YA; Mohd Kasim NA; Mohd Nawawi H BMC Pediatr; 2019 Apr; 19(1):106. PubMed ID: 30975109 [TBL] [Abstract][Full Text] [Related]
23. Epidemiology of familial hypercholesterolaemia: Community and clinical. Vallejo-Vaz AJ; Ray KK Atherosclerosis; 2018 Oct; 277():289-297. PubMed ID: 30270061 [TBL] [Abstract][Full Text] [Related]
24. Estimation of the prevalence of familial hypercholesterolaemia in a rural Afrikaner community by direct screening for three Afrikaner founder low density lipoprotein receptor gene mutations. Steyn K; Goldberg YP; Kotze MJ; Steyn M; Swanepoel AS; Fourie JM; Coetzee GA; Van der Westhuyzen DR Hum Genet; 1996 Oct; 98(4):479-84. PubMed ID: 8792826 [TBL] [Abstract][Full Text] [Related]
25. Effectiveness of alternative strategies to define index case phenotypes to aid genetic diagnosis of familial hypercholesterolaemia. Clarke RE; Padayachee ST; Preston R; McMahon Z; Gordon M; Graham C; Crook MA; Wierzbicki AS Heart; 2013 Feb; 99(3):175-80. PubMed ID: 23213176 [TBL] [Abstract][Full Text] [Related]
26. Screening for hypercholesterolaemia versus case finding for familial hypercholesterolaemia: a systematic review and cost-effectiveness analysis. Marks D; Wonderling D; Thorogood M; Lambert H; Humphries SE; Neil HA Health Technol Assess; 2000; 4(29):1-123. PubMed ID: 11109029 [TBL] [Abstract][Full Text] [Related]
27. Clinical Implications of Monogenic Versus Polygenic Hypercholesterolemia: Long-Term Response to Treatment, Coronary Atherosclerosis Burden, and Cardiovascular Events. D'Erasmo L; Minicocci I; Di Costanzo A; Pigna G; Commodari D; Ceci F; Montali A; Brancato F; Stanca I; Nicolucci A; Ascione A; Galea N; Carbone I; Francone M; Maranghi M; Arca M J Am Heart Assoc; 2021 May; 10(9):e018932. PubMed ID: 33890476 [TBL] [Abstract][Full Text] [Related]
28. Familial Hypercholesterolaemia in the Malaysian Community: Prevalence, Under-Detection and Under-Treatment. Chua YA; Razman AZ; Ramli AS; Mohd Kasim NA; Nawawi H J Atheroscler Thromb; 2021 Oct; 28(10):1095-1107. PubMed ID: 33455995 [TBL] [Abstract][Full Text] [Related]
29. Low-density lipoprotein apheresis: an evidence-based analysis. Medical Advisory Secretariat Ont Health Technol Assess Ser; 2007; 7(5):1-101. PubMed ID: 23074505 [TBL] [Abstract][Full Text] [Related]
30. Mutations causative of familial hypercholesterolaemia: screening of 98 098 individuals from the Copenhagen General Population Study estimated a prevalence of 1 in 217. Benn M; Watts GF; Tybjærg-Hansen A; Nordestgaard BG Eur Heart J; 2016 May; 37(17):1384-94. PubMed ID: 26908947 [TBL] [Abstract][Full Text] [Related]
31. Impact of genetic defects on coronary atherosclerosis in patients suspected of having familial hypercholesterolaemia. Descamps OS; Gilbeau JP; Luwaert R; Heller FR Eur J Clin Invest; 2003 Jan; 33(1):1-9. PubMed ID: 12492446 [TBL] [Abstract][Full Text] [Related]
36. Impact of clinical signs and genetic diagnosis of familial hypercholesterolaemia on the prevalence of coronary artery disease in patients with severe hypercholesterolaemia. Tada H; Kawashiri MA; Nohara A; Inazu A; Mabuchi H; Yamagishi M Eur Heart J; 2017 May; 38(20):1573-1579. PubMed ID: 28159968 [TBL] [Abstract][Full Text] [Related]